SULT1E1

Chr 4

sulfotransferase family 1E member 1

Also known as: EST, EST-1, ST1E1, STE

The SULT1E1 protein is a sulfotransferase enzyme that catalyzes sulfate conjugation of estradiol and estrone, serving as a key regulator of estrogen homeostasis by inactivating these hormones through sulfation. The gene is highly constrained against loss-of-function variants, but no Mendelian diseases have been definitively associated with SULT1E1 mutations in current clinical genetics practice. Research suggests potential roles in neurodevelopment through metabolism of gut bacteria-derived compounds that may affect oligodendrocyte maturation and brain connectivity.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.27
Clinical SummarySULT1E1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
22 unique Pathogenic / Likely Pathogenic· 49 VUS of 86 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.27LOEUF
pLI 0.000
Z-score 0.78
OE 0.78 (0.501.27)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.12Z-score
OE missense 0.97 (0.851.11)
148 obs / 152.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.78 (0.501.27)
00.351.4
Missense OE0.97 (0.851.11)
00.61.4
Synonymous OE0.91
01.21.6
LoF obs/exp: 12 / 15.3Missense obs/exp: 148 / 152.2Syn Z: 0.52
DN
0.7229th %ile
GOF
0.6541th %ile
LOF
0.1895th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

86 submitted variants in ClinVar

Classification Summary

Pathogenic21
Likely Pathogenic1
VUS49
Likely Benign5
Benign2
21
Pathogenic
1
Likely Pathogenic
49
VUS
5
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
21
0
21
Likely Pathogenic
0
0
1
0
1
VUS
0
36
13
0
49
Likely Benign
0
1
1
3
5
Benign
0
0
0
2
2
Total03736578

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SULT1E1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →